Bergapten
CAS No. 484-20-8
Bergapten ( —— )
产品货号. M14621 CAS No. 484-20-8
5-甲氧基补骨脂素是一种天然存在的线性呋喃香豆素,已成功与紫外线 (UV) A 照射[补骨脂素加紫外线 (PUVA)] 结合使用来治疗牛皮癣和白癜风。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 500MG | ¥551 | 有现货 |
|
| 1G | ¥948 | 有现货 |
|
生物学信息
-
产品名称Bergapten
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述5-甲氧基补骨脂素是一种天然存在的线性呋喃香豆素,已成功与紫外线 (UV) A 照射[补骨脂素加紫外线 (PUVA)] 结合使用来治疗牛皮癣和白癜风。
-
产品描述5-Methoxypsoralen, a naturally occurring linear furocoumarin, has been successfully used in combination with ultraviolet (UV) A irradiation [psoralen plus UV (PUVA)] to manage psoriasis and vitiligo; inhibit proliferation in the human hepatocellular carcinoma cell line.(In Vitro):There is decreased N-acetyltransferase (NAT) activity in SC-M1 cells at concentrations of Bergapten (5-Methoxypsoralen, 5-MOP) from 0.05 mM to 25 mM, but no obvious dose-dependent effect is found between these doses (r=0.5687). In COLO 205 cells, there is decreased NAT activity at low doses of Bergapten (0.05 mM and 0.5 mM) and increased NAT activity at a high dose (50 mM). Bergapten induces a dosedependent effect in our experimental concentrations on COLO 205 cells (r=0.8912); a promotion effect at a higher dose (50 mM) and an inhibition effect at lower doses (0.05-0.5 mM), while the concentrations 5-25 mM has no significant difference compared with the control regimen. Bergapten (5-Methoxypsoralen) exerts inhibitory effects on diabetes-related osteoporosis via the regulation of the PI3K/AKT, JNK/MAPK and NF-κB signaling pathways in osteoprotegerin knockout mice. Bergapten has also been shown to significantly inhibit the production of pro-inflammatory cytokines. Bergapten exhibits the ability to significantly inhibit RANKL-RANK signaling transduction, and to suppress the activation of the PI3K/AKT, JNK/MAPK and NF-κB signaling pathways, thus protecting trabecular structure and decreasing osteoclastogenic differentiation. (In Vivo):The metabolic activity of NAT of the rat colon is higher than that of the stomach, and Bergapten (5-Methoxypsoralen, 5-MOP) causes a decrease of AF concentration in the stomach at the 24-h time-period. The concentrations of AAF in the stomach and colon are low. Although DMSO (solvent) influenced the metabolism of AAF, compared with the control regimen, Bergapten still causes an increase in the further metabolism of AAF, and a decrease in the concentration of AAF in the stomach at 24 h, and in the colon during the 24- to 72-h time-period.
-
体外实验There is decreased N-acetyltransferase (NAT) activity in SC-M1 cells at concentrations of Bergapten (5-Methoxypsoralen, 5-MOP) from 0.05 mM to 25 mM, but no obvious dose-dependent effect is found between these doses (r=0.5687). In COLO 205 cells, there is decreased NAT activity at low doses of Bergapten (0.05 mM and 0.5 mM) and increased NAT activity at a high dose (50 mM). Bergapten induces a dosedependent effect in our experimental concentrations on COLO 205 cells (r=0.8912); a promotion effect at a higher dose (50 mM) and an inhibition effect at lower doses (0.05-0.5 mM), while the concentrations 5-25 mM has no significant difference compared with the control regimen. Bergapten (5-Methoxypsoralen) exerts inhibitory effects on diabetes-related osteoporosis via the regulation of the PI3K/AKT, JNK/MAPK and NF-κB signaling pathways in osteoprotegerin knockout mice. Bergapten has also been shown to significantly inhibit the production of pro-inflammatory cytokines. Bergapten exhibits the ability to significantly inhibit RANKL-RANK signaling transduction, and to suppress the activation of the PI3K/AKT, JNK/MAPK and NF-κB signaling pathways, thus protecting trabecular structure and decreasing osteoclastogenic differentiation.
-
体内实验The metabolic activity of NAT of the rat colon is higher than that of the stomach, and Bergapten (5-Methoxypsoralen, 5-MOP) causes a decrease of AF concentration in the stomach at the 24-h time-period. The concentrations of AAF in the stomach and colon are low. Although DMSO (solvent) influenced the metabolism of AAF, compared with the control regimen, Bergapten still causes an increase in the further metabolism of AAF, and a decrease in the concentration of AAF in the stomach at 24 h, and in the colon during the 24- to 72-h time-period.
-
同义词——
-
通路Metabolic Enzyme/Protease
-
靶点P450
-
受体CYP
-
研究领域Cancer
-
适应症——
化学信息
-
CAS Number484-20-8
-
分子量216.19
-
分子式C12H8O4
-
纯度>98% (HPLC)
-
溶解度DMSO: 5 mg/mL (23.12 mM)
-
SMILESCOC1=C2C=CC(=O)OC2=CC2=C1C=CO2
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Panno ML, et al. Breast Y Res Treat, 2012, 136(2), 443-455.
产品手册
关联产品
-
Ginsenoside F1
人参皂苷 F1 是人参皂苷 Rg1 的酶促修饰衍生物,对紫外线 B 诱导的细胞凋亡的保护与人参皂苷 F1 介导的对紫外线 B 诱导的 Bcl-2 和 Brn-3a 表达下调的抑制密切相关。
-
N-Desethyl Chloroqui...
N-Desethyl Chloroquine Hydrochloride ((±)-Desethylchloroquine 2HCl) is a desethylchloroquine derivative. desethylchloroquine competitively inhibits cyp2d1 /6-mediated reactions in vitro and in vivo.
-
N-Desmethyl-Apalutam...
N-Desmethyl-Apalutamide 是一种效力较低的雄激素受体拮抗剂,是一种活性 Apalutamide 代谢物。
021-51111890
购物车()
sales@molnova.cn

